cognitive dysfunction in type 2 diabetes mellitus patients

Not Applicable

• Conditions: Health Condition 1: E116- Type 2 diabetes mellitus with other specified complications

• Registration Number: CTRI/2019/01/016877
• Lead Sponsor: Kasturba Medical College Manipal

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 24 November 2021

Recruitment & Eligibility

• Status: ot Yet Recruiting
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

1st objective:1) All T2DM patients above 20 years of age with informed consent visiting the hospital of various age groups ready to volunteer

2)Minimum of 5 years of formal education

3)Patients having all the co-morbidities including hypo and hyperthyroidism, hypertension, CAD, kidney and liver diseases, HIV, Vitamin B12 deficiency and any other infectious diseases

2nd objective- 1)T2DM patients above 60 years of age with more than 10 years of diabetes without any complications who are ready to volunteer with informed consent

Exclusion Criteria

1st objective: 1)T2DM patients who are severely sick and unco-operative for performing the cognitive tests

2)Patients with visual impairment, confusion and delirium

3)Exclusion criteria for the 2ndobjective -T2DM patients suffering from hypo and hyper thyroidism, hypertension, HIV, Vitamin B12 deficiency, kidney, liver and other infectious diseases

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Assessing cognitive dysfunction in type 2 diabetes mellitus patients and to find out whether there is a possibility of getting certain class of sphingolipids which may be up-regulated and down-regulated in T2DM patients suffering from CD. This information may be helpful for therapeutic intervention studies in future.Timepoint: one time

Secondary Outcome Measures

Name	Time	Method
to find out whether there is a possibility of getting certain class of sphingolipids which may be up-regulated and down-regulated in T2DM patients suffering from CD. This information may be helpful for therapeutic intervention studies in future.Timepoint: one time